HIF-1 alpha based DNA vaccine (Inovio Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIF-1 alpha based DNA vaccine (Inovio Pharmaceuticals)
Drug Alias Namehypoxia inducible factor-1 alpha based DNA vaccine (Inovio Pharmaceuticals)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionHypoxia-inducible factor 1 alpha modulators
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsIschemiaPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsIschemiaPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A